Hui-ling Chiou

Prof. Dr. Hui-ling Chiou


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2013 in Archives of Toxicology
Verified
Journal Article
Open access
PDF file
Ming-Ju HsiehMing-Ju Hsieh
Ming-Ju Hsieh
TTTe-Lung Tsai
Te-Lung Tsai
YHYih-Shou Hsieh
Yih-Shou Hsieh
CWChau-Jong Wang
Chau-Jong Wang
HCHui-ling Chiou
Hui-ling Chiou
Our previous study has revealed that dioscin, a compound with anti-inflammatory, lipid-lowering, anticancer and hepatoprotective effects, may induce autophagy in hepatoma cells. Autophagy is a lysosomal degradation pathway that is essential for cell survival and tissue homeostasis. In this study, the role of autophagy and related signaling pathways during dioscin-induced apoptosis in human lung cancer cells was investigated. Results from 4′-6-diamidino-2-phenylindole and annexin-V/PI double-staining assay showed that caspase-3- and caspase-8-dependent, and dose-dependent apoptoses were detected after a 24-h dioscin treatment. Meanwhile, autophagy was detected as early as 12 h after an exposure to low-dose dioscin, as indicated by an up-regulated expression of LC3-II and beclin-1 proteins. Blockade of autophagy with bafilomycin A1 or 3-methyladenine sensitized the A549 and H1299 cells to apoptosis. Treatment of A549 and H1299 cells with dioscin caused a dose-dependent increase in ERK1/2 and JNK1/2 activity, accompanied with a decreased PI3K expression and decreased phosphorylation of Akt and mTOR. Taken together, this study demonstrated for the first time that autophagy occurred earlier than apoptosis during dioscin-induced human lung cancer cell line apoptosis. Dioscin-induced autophagy via ERK1/2 and JNK1/2 pathways may provide a protective mechanism for cell survival against dioscin-induced apoptosis to act as a cytoprotective reaction.

7 February 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CYChao-Bin Yeh
Chao-Bin Yeh
Ming-Ju HsiehMing-Ju Hsieh
Ming-Ju Hsieh
Yi-Hsien HsiehYi-Hsien Hsieh
Yi-Hsien Hsieh
MCMing-Hsien Chien
Ming-Hsien Chien
HCHui-ling Chiou
Hui-ling Chiou
Shun-Fa YangShun-Fa Yang
Shun-Fa Yang
The rate of morbidity and mortality of hepatocellular carcinoma (HCC) in Taiwan has not lessened because of difficulty in treating tumor metastasis. Norcantharidin (NCTD) is currently used as an anticancer drug for hepatoma, breast cancer, and colorectal adenocarcinoma. NCTD possesses various biological anticancer activities, including apoptosis. However, detailed effects and molecular mechanisms of NCTD on metastasis are unclear. Thus, HCC cells were subjected to treatment with NCTD and then analyzed to determine the effects of NCTD on cell metastasis. Modified Boyden chamber assays revealed that NCTD treatment inhibited cell migration and invasion capacities of HCC cells substantially. Results of zymography and western blotting showed that activities and protein levels of matrix metalloproteinase-9 (MMP-9) and urokinase plasminogen activator (u-PA) were inhibited by NCTD. Western blot analysis showed that NCTD inhibits phosphorylation of ERK1/2. Testing of mRNA level, quantitative real-time PCR, and promoter assays evaluated the inhibitory effects of NCTD on MMP-9 and u-PA expression in HCC cells. The chromatin immunoprecipitation (ChIP) assay for analyzing the genomic DNA sequences bound to these proteins was reactive to the transcription protein nuclear factor (NF)-kappaB, which was inhibited by NCTD. The expression of NF-kappa B was measured by western blot analysis, which revealed decreased nuclear-factor DNA-binding activity after NCTD treatment. NCTD inhibited MMP-9 and u-PA expression through the phosphorylation of ERK1/2 and NF-kappaB signaling pathway which serves as a powerful chemopreventive agent in HCC cell metastasis.

27 May 2014 in British Journal of Pharmacology
Verified
Journal Article
Closed access
PDF file
Ming-Ju HsiehMing-Ju Hsieh
Ming-Ju Hsieh
CLChiao‐Wen Lin
Chiao‐Wen Lin
SYShun‐Fa Yang
Shun‐Fa Yang
MCMu-Kuan Chen
Mu-Kuan Chen
HCHui-ling Chiou
Hui-ling Chiou

28 May 2019 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
CYChen-Lin Yu
Chen-Lin Yu
Shun-Fa YangShun-Fa Yang
Shun-Fa Yang
THTung-Wei Hung
Tung-Wei Hung
CLChia-Liang Lin
Chia-Liang Lin
Yi-Hsien HsiehYi-Hsien Hsieh
Yi-Hsien Hsieh
HCHui-ling Chiou
Hui-ling Chiou
Hepatocellular carcinoma (HCC) is the one of the most common cancers worldwide. Because the side effects of current treatments are severe, new effective therapeutic strategies are urgently required. Pterostilbene (PT), a natural analogue of resveratrol, has diverse pharmacologic activities, including antioxidative, anti-inflammatory and antiproliferative activities. Here we demonstrated that PT inhibits HCC cell growth without the induction of apoptosis in an endoplasmic reticulum (ER) stress- and autophagy-dependent manner. Mechanistic studies indicated that the combination of salubrinal and PT modulates ER stress-related autophagy through the phospho-eukaryotic initiation factor 2α/activating transcription factor-4/LC3 pathway, leading to a further inhibition of eIF2α dephosphorylation and the potentiation of cell death. An in vivo xenograft analysis revealed that PT significantly reduced tumour growth in mice with a SK-Hep-1 tumour xenograft. Taken together, our results yield novel insights into the pivotal roles of PT in ER stress- and autophagy-dependent cell death in HCC cells.

1 June 2015 in Oral Oncology
Verified
Journal Article
Closed access
CKChung-Po Ko
Chung-Po Ko
CLChiao-Wen Lin
Chiao-Wen Lin
MCMu-Kuan Chen
Mu-Kuan Chen
SYShun-Fa Yang
Shun-Fa Yang
HCHui-ling Chiou
Hui-ling Chiou
Ming-Ju HsiehMing-Ju Hsieh
Ming-Ju Hsieh

10 November 2010 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
Ming-Ju HsiehMing-Ju Hsieh
Ming-Ju Hsieh
HYHsieh Yih‐Shou
Hsieh Yih‐Shou
CTChen Tzy‐Yen
Chen Tzy‐Yen
HCHui-ling Chiou
Hui-ling Chiou